SPONSOR
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Total Trials
2
Recruiting
2
Phases
EARLY_Phase 1
Conditions studied: Hematolymphoid MalignanciesNon-Hodgkin Lymphoma (NHL)Acute Lymphoblastic Leukemia (ALL), Adult
PersonGen BioTherapeutics (Suzhou) Co., Ltd. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Hematolymphoid Malignancies, Non-Hodgkin Lymphoma (NHL), Acute Lymphoblastic Leukemia (ALL), Adult.
The trial portfolio spans EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — PersonGen BioTherapeutics (Suzhou) Co., Ltd.
How many clinical trials has PersonGen BioTherapeutics (Suzhou) Co., Ltd. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by PersonGen BioTherapeutics (Suzhou) Co., Ltd., of which 2 are actively recruiting participants. These trials cover conditions including Hematolymphoid Malignancies, Non-Hodgkin Lymphoma (NHL), Acute Lymphoblastic Leukemia (ALL), Adult. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does PersonGen BioTherapeutics (Suzhou) Co., Ltd. research focus on?
PersonGen BioTherapeutics (Suzhou) Co., Ltd. clinical trials span Hematolymphoid Malignancies, Non-Hodgkin Lymphoma (NHL), Acute Lymphoblastic Leukemia (ALL), Adult. The research pipeline includes EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a PersonGen BioTherapeutics (Suzhou) Co., Ltd. clinical trial?
To participate in a PersonGen BioTherapeutics (Suzhou) Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all PersonGen BioTherapeutics (Suzhou) Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by PersonGen BioTherapeutics (Suzhou) Co., Ltd.
NCT07338604 EARLY_Phase 1
Recruiting
Clinical Study of UTAA07 Injection in the Treatment of Hematologic and Lymphatic Systemic Malignancies
Hematolymphoid Malignancies
NCT07312630 EARLY_Phase 1
Recruiting
Clinical Study of LV009 Injection for the Treatment of Relapsed/Refractory CD19-Positive Hematologic and Lymphoid Malignancies
Non-Hodgkin Lymphoma (NHL)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology